These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 25029448)
1. Which drug should we use for stroke prevention in atrial fibrillation? Lau YC; Lip GY Curr Opin Cardiol; 2014 Jul; 29(4):293-300. PubMed ID: 25029448 [TBL] [Abstract][Full Text] [Related]
2. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation and stroke prevention: brief observations on the last decade. Lip GY Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):403-6. PubMed ID: 24650307 [TBL] [Abstract][Full Text] [Related]
4. Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin. Lanitis T; Cotté FE; Gaudin AF; Kachaner I; Kongnakorn T; Durand-Zaleski I J Med Econ; 2014 Aug; 17(8):587-98. PubMed ID: 24831811 [TBL] [Abstract][Full Text] [Related]
5. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions. Cheng JW; Barillari G J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983 [TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence. Martínez-Rubio A; Dan GA; Kaski JC Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):933-47. PubMed ID: 24948333 [TBL] [Abstract][Full Text] [Related]
13. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation. Aguilar MI; Kuo RS; Freeman WD Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498 [TBL] [Abstract][Full Text] [Related]
14. Direct thrombin and factor Xa inhibition for stroke prevention in patients with atrial fibrillation. Galanis T; Merli GJ Hosp Pract (1995); 2013 Feb; 41(1):26-36. PubMed ID: 23466965 [TBL] [Abstract][Full Text] [Related]
15. Novel Anticoagulants in Atrial Fibrillation: A Primer for the Primary Physician. Mookadam M; Shamoun FE; Mookadam F J Am Board Fam Med; 2015; 28(4):510-22. PubMed ID: 26152444 [TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation. Alberts MJ; Eikelboom JW; Hankey GJ Lancet Neurol; 2012 Dec; 11(12):1066-81. PubMed ID: 23153406 [TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation. Liew A; Eikelboom JW; O'Donnell M Curr Opin Cardiol; 2012 Jul; 27(4):331-9. PubMed ID: 22573171 [TBL] [Abstract][Full Text] [Related]
18. [Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran]. Szapary L; Fehér G; Bosnyák E; Deli G; Csécsei P Ideggyogy Sz; 2013 May; 66(5-6):165-74. PubMed ID: 23909016 [TBL] [Abstract][Full Text] [Related]
19. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation. Berman JP; Halperin JL Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966 [TBL] [Abstract][Full Text] [Related]
20. Effective practical management of patients with atrial fibrillation when using new oral anticoagulants. Cox JL Ann Med; 2015 Jun; 47(4):278-88. PubMed ID: 25850527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]